europcr presentation

You are using an outdated browser. Please upgrade your browser to improve your experience.

European Association for Percutaneous Cardiovascular Interventions

Annual Meeting 2024

Le Palais des Congrès de Paris, 2 Pl de la Prte Maillot, 75017 Paris

EuroPCR 2024 is the World-Leading course and annual meeting of interventional cardiovascular medicine is organized by European Association of Percutaneous Cardiovascular Interventions (EAPCI) and will be held from May 14 - 17, 2024 at Paris Convention Center, Paris, Ile-de-France, France. The main scientific programme offered by euroPCR features debates, live case presentations and core lectures. The gathering includes debuts a sizable display area where participants can learn about leading medical techniques and approaches.

PCR - Sharing knowledge, experience and practice in cardiovascular interventional medicine.

The mission of PCR is to serve the needs of each individual patient by helping the cardiovascular community to share knowledge, experience and practice. Its activities cover a large spectrum, from the organisation of annual courses in Europe, Asia and the Middle East to editing a scientific journal, publishing textbooks as well as providing training sessions and online courses on thematic subjects. Courses are based on themes like Coronary Interventions, Hypertension and Stroke, Peripheral Interventions, Valvular Disease and Heart Failure.

Reserve Your Hotel

Event / conference & exhibition schedule.

Discover a Programme designed for you, by you:-

This year #EuroPCR is proud to reveal for the very first time, a Programme carefully built based on essential feedback received from the PCR Community. We asked for your insights and suggestions, and they have been crucial in shaping a Programme that promises to be both highly relevant and exciting.

• A programme designed for everybody, from cardiologists to Nurses and Allied Professionals, to imagers and more.
• Regardless of your skills or expertise, the Course will have a positive impact on your daily practice.

Housing Information

Get best in class hotels available during the event; we will guide you through the complete travel services related to the event. Our conferences operations & services team can handle everything you need.

Accommodation Services

We provide complete hotel booking services for various events held worldwide to the international attendees. We will be happy to make the requisite arrangements for you. Our excellent network through the hospitality industry and our accessibility to the best reservation systems across the countries enables us to extend highly satisfactory services to our esteemed clients.

Tourist Places in Paris

Canal Saint-Martin, Eiffel Tower, Louvre Museum, Arc de Triomphe, Palace of Versailles, Montmartre, Tuileries Garden, Moulin Rouge, Disneyland Paris, Place de la Concorde, Sainte-Chapelle, Catacombs of Paris, Montparnasse Tower, Rodin Museum, Palais Garnier.

Our Mission

Our mission is to provide world-class, safest and the best value trips to our clients through our experience and efficiency. We know that every detail is important, which will always makes the difference so that your travel experience will be exceptional.

Frequent asked questions

Q. how can i get information about event registration.

A. Registration for the event is handled by a different vendor. Please see the registration page of the event's website for further information or to log in to the registration system.

Q. How can I register?

A. We offer individual registrations (one registration/one payment) and group registrations (one paying party for several participants).

Q. What’s included in our registration fees?

A. At EuroPCR, ALL BADGES will give access to:

• All scientific sessions (subject to room capacity)
• The exhibition areas
• 40 years of Angioplasty Expo (Level 3)
• Buffets, coffee breaks and lunch bags
• The EuroPCR Course bag (except for Exhibitor badges’ holders)
• Daily journal (within the limits of available stock)
• Glance Programme
• EuroIntervention Journal May issue and its Supplement (within the limits of available stock)
• Trials book (within the limits of available stock)
• PCR Courses App (subject to your device compatibility)
• Free Textbook-EAPCI chapters during EuroPCR

Q. What languages are spoken?

A. English is the official language at EuroPCR.

Q. Can I access my early bird fee benefit if I pay onsite?

A. The early bird fee does not apply to onsite registrations.

Q. What Are My Options When My Hotel Choice Is Unavailable?

A. Hotels rooms offered through discounted event rates are limited and available on a first-come, first-served basis. While conducting your search, the online system reflects up-to-the-minute availability and booking options.

Register early before its too late.

Affordable event packages.

We offer affordable and convenient housing for most of the conferences, congress and meetings held worldwide. Whether you are looking for individual housing or group housing, we have best hotel list for you near the convention centre. Below are the types of hotels available for you as per the star rating.

5 STAR HOTEL

$350 - $300.

Five-star hotels are considered as having the highest standard rating. These hotels offer multiple room options with luxurious and tasteful decorations and maximum comfort. Rooms in five-star hotels are considerably bigger than those in lower ranked hotels. Even the most basic rooms in a five-star hotel are spacious and allow guests to experience luxury.

4 STAR HOTEL

$300 - $250.

A hotels with four-star rating shares similar amenities as a three-star hotel, but it includes an additional restaurant and bar option, concierge, and a swimming pool, among others. A large vary of facilities and superior design qualities square measure typically complemented by service standards that mirror the various and discerning needs of the guest.

3 STAR HOTEL

$250 - $200.

Hotels with a three-star rating have several room options, such as Deluxe, Suite, or Premier. Rooms may also be given varying names depending on the hotel’s preference. There are also improvements in the availability of in-house amenities, such as a gymnasium, a full-service restaurant, as well as business facilities and a kiosk.

Event venue & Contact Us

Below is the complete detail of event venue. If you need further help or support, please fill below form, our team will respond you quickly.

Get In Touch With Us Don’t worry we love to help

Send your query / detail @, [email protected], housing request.

Find your perfect hotel near venue

• Associations
• Working Groups
• Escardio.org
• ESC eLearning

Show navigation Hide navigation

• European Society of Cardiology
• ESC Press Office
• Press releases

In Person in Paris and online EuroPCR celebrates the best of both worlds

From 17-20 May 2022, a new Blended version of the World-Leading annual Course in interventional cardiovascular medicine will be taking place in Paris and all over the world.

EuroPCR is celebrating being back home in Paris, in-person, for the first time in 3 years. This year’s international Course will see both a complete on-site programme and a full digital experience, bringing the community together to share and learn.

As the official annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), EuroPCR is a patient-oriented Course built by and for the community covering the latest innovations and advances in cardiovascular interventions. Interventional cardiologists, cardiac surgeons, imaging specialists, radiologists, nurses, allied professionals and other practitioners will be joined by researchers, innovators and industry representatives to address interventions for coronary and peripheral vessels, for structural heart disease including valves, for hypertension, heart failure and stroke.

As one PCR catchphrase has it, ‘it’s all about the patient’. But it’s also ‘all about learning’, and over the challenging years between the last in-person EuroPCR in 2019 and this one, a lot has been learned, notably just how powerful digital can be. Online learning at EuroPCR has made a decade’s progress in just a couple of years and much effort has gone into ensuring an enriched experience for everyone at EuroPCR 2022: both online participants accessing exclusive content, and the participants in Paris, getting even wider, even more diverse input from colleagues all over the world.

EuroPCR 2022 is more than just on-line and in-person, it’s fully blended, with all participants encouraged to share comments and ask questions during live-streamed sessions in real time (orally or via the mobile app for in-person participants and via the chat for those online). And on the priority digital side, there’s the new concept « EuroPCR+ », a digital channel broadcasting live news, discussions and interviews, with repeat broadcasts 24 hours a day, giving participants the chance to catch up with the big news of each day and get in-depth scientific insight into key topics. 

A key element of the Course will be the opportunity for hands-on experience in the Training Village and Simulation-based learning, while presentations of the latest devices and sessions on innovation in cardiovascular medicine - such as artificial intelligence and the cath lab of the future - will generate much interest.

Over 700 participants will see their scientific abstracts, clinical cases, images, innovations and late-breaking trials showcased, with awards given for the best abstract presentation, the best clinical case, the best innovation and the best personalised vascular care project.

Key features: • 4-day Course • 21 session rooms, including 3 TV studios streaming live • 10 digital channels • A 24 hour/day digital channel (EuroPCR+) • 300+ educational sessions • 400+ hours of Programme content • the return of real time LIVE cases from 4 LIVE Centres • 1,680+ submissions received • 70+ Industry booths

A global outreach: • 45 National Societies and Working Groups in the onsite Scientific Programme • 107 Countries represented by Course participants as of 27 April • 63 Countries represented by the Core Team and Faculty • 750+ Presenters from 78 different countries • 4 LIVE Centres in 3 different countries • 38 Official EuroPCR Ambassadors spread over 6 continents • 3 TV studios in Paris live streaming sessions for worldwide access

Some highlights from the 400 hours of programme content in the upcoming Course Hot Line sessions The latest data from internationally recognised trials will be released at EuroPCR 2022 during dedicated Hot Line and Late-breaking Trial sessions.

Other sessions of interest The return of LIVE cases with: NSTEMI PCI, OCT in MVD PCI, robotic PCI, TAVI and transcatheter mitral edge interventions. 

Simulation-based learning on topics such as: Image-guided bifurcation stenting - live from Japan; Antegrade CTO; TAVI; Bifurcation techniques; Transseptal puncture for mitral interventions. 

Special Sessions : 20 years of TAVI; The Cathlab of Tomorrow, already here Today; Hypertension Management. 

A programme dedicated to Nurses and Allied Professionals , onsite and live-streamed. 

The EAPCI-PCR Fellows Course , a track taking place throughout the four days. 

PCR Innovators Day , following which the Jon DeHaan Foundation will be rewarding the best innovation with a generous $200,000 grant.

The return of the renowned PCR’s Got Talent competition.

A Celebration The theme for this year’s Course is “Let’s Celebrate”, in particular the joy of being “back home” in Paris, meeting face to face, but there are also several anniversaries to be celebrated:

20 years since the first Transcatheter Aortic Valve Implantation (TAVI) was performed by Professor Alain Cribier at the Charles Nicolle University Hospital in Rouen, France. 30 years since Dr Ferdinand Kiemeneij performed the first successful transradial coronary angioplasty procedure at Onze Lieve Vrouw Gasthuis in Amsterdam, Netherlands. The 17th World Hypertension Day on 17th May. The 10th anniversary of the EAPCI-PCR textbook, the first of its kind, all-inclusive patient-centred reference book promoting good, evidence-based clinical practices. The 200th issue of EuroIntervention, the official journal of EuroPCR and the EAPCI was published in January 2022. And it’s the 20th anniversary of the digital gateway to PCR, PCRonline.

Notes to editor

About EuroPCR 2022 The World-Leading Course in interventional cardiovascular medicine and the official annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) will take place from 17 to 20 May 2022, in Paris and online. The detailed Course Programme is available on: www.pcronline.com/Courses/EuroPCR/Programme/2022/Course-Programme

About PCR The mission of PCR is to serve the needs of each individual patient by helping the cardiovascular community to share knowledge, experience and practice. PCR offers a large range of many other educational meetings and resources for the continuing education of the interventional cardiovascular community. These include major annual Courses across the globe, e-Learning with high-profile PCR Webinars, Courses specifically dedicated to valvular heart disease, tailor-made PCR Seminars on specific topics, online resources and medical publications such as EuroIntervention, the official journal of the EAPCI. Gateways to all PCR activities are available on www.pcronline.com

For further information, please contact Sally Collingridge, PCR Marketing Communication Manager: [email protected]

About the EAPCI The European Association of Percutaneous Cardiovascular Interventions (EAPCI) is a branch of the European Society of Cardiology. Its mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions. This dynamic association represents a community of over 7,000 healthcare professionals by helping them remain up to date in the constantly evolving field of PCI by publishing research and providing training and certification programmes. The EAPCI also advocates for the best possible access to life saving treatments for patients through data-based advocacy at a European level.

HELP FOR JOURNALISTS TO COVER EUROPCR 2022 Register and attend EuroPCR 2022 as a journalist Open to accredited journalists, free of charge. Journalists must hold a valid press card and/or provide a letter of assignment from a recognised publication. To register as press, go to https://www.pcronline.com/Courses/EuroPCR/Press EuroPCR press releases can be found at https://www.pcronline.com/News/PCR-Press-Releases For any press-related enquiries, please contact EuroPCR Press Coordinator, Isabelle Uzielli: [email protected]

• ESC Board and Committees
• ESC Policies
• Statutes & Reports
• Press Releases
• ESC Congress
• ESC Cardio Talk
• Our Offices
• Conference Facilities
• Jobs in Cardiology
• Terms & Conditions
• Update your cookie settings

  Need help?

  Help centre   Contact us

© 2024 European Society of Cardiology. All rights reserved.

• News Releases

EuroPCR 2023 – The interventional cardiovascular community is gathering in Paris to learn, share, and shape the future of patient care worldwide

The official meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology is taking place on 16-19 May 2023 at the Palais des Congrès - Paris, France.

EuroPCR, the annual world-leading Course in interventional cardiovascular medicine, has been taking place for over 30 years. It is tailored for all those dedicated to the sharing of knowledge and skills, and improvement of patient care worldwide: interventional cardiologists, cardiac surgeons, imaging specialists, radiologists, nurses, allied professionals and other practitioners, as well as researchers, innovators and industry representatives. The 4-day meeting addresses interventions for coronary and peripheral vessels, for the structural heart including valves, for hypertension, heart failure and stroke, while keeping the community up to date with all the very latest innovations in the field.

To benefit from the full value of the renowned EuroPCR learning experience , participants are encouraged to join the Course onsite. However, a digital package provides those connecting on the user-friendly platform with a selection of live-streamed sessions, and the opportunity to interact in real time with their peers in Paris and worldwide.

Hands-on training will once again be at the forefront of the Course. Participants of all levels will be able to sharpen their practical skills in a total of 220 workshops taking place in the 902 sqm Training Village, the innovative Simulation-based Learning Room and the Hands On Lab for small groups of participants.

50% of the Course is built from among the worldwide community’s total of 2,400 submissions to this year’s Calls for Scientific Abstracts, Clinical Cases, Images, Innovations and Late-Breaking Trials. 879 presenters from 78 different countries will be sharing their work. There were notably a record-breaking 129 late-breaking trials submitted to EuroPCR 2023, and the 50 being presented onsite will share the latest data with the community. Details of the full programme here: https://www.pcronline.com/Courses/EuroPCR/Programme/2023/2023-Course-Programme

The PCR’s Got Talent scientific abstract competition for under 40’s consists of three onsite rounds. It has met with great popularity since it first took place in 2015. Competitors benefit from onsite professional coaching for their communication and presentation skills, and the winner is announced in the Awards Ceremony. They obtain onsite and online visibility for their work, and an invitation to participate as Faculty in the subsequent edition of the Course.

Key features :

• 4-day Course 
• 21 session rooms 
• 320+ educational sessions
• 450+ hours of Programme content
• LIVE demonstrations
• 902 sqm Training Village
• TV studio in Paris live streaming sessions for worldwide access
• 2,400+ submissions received
• 85+ Industry booths in the Exhibition Area

Focus on international collaboration :

• 65 National Societies and Working Groups in the onsite Scientific Programme
• 126 Countries represented by Course participants, as of 01 May
• 79 Countries represented by the 798 Faculty
• 879 Presenters from 78 different countries
• 5 LIVE Centres in 4 different countries

A special theme

This year, the Course will be marking the 30 th anniversary of primary PCI for STEMI. Since its invention, this life-saving PCI procedure has saved literally millions of people all around the globe. This will be the focus of the Welcome Ceremony, during which the Andreas Grüntzig Ethica Award will also be announced.

Other sessions of interest

LIVE cases are covering topics such as: distal left main, aortic stenosis, calcified lesions, bifurcation lesions, TAVI, transcatheter bicuspid valve replacement, r obotics, and multivessel disease

Simulation-based learning: practical sessions on a wide range of topics involve step-by-step demonstrations using simulators, alongside opportunities for hands-on practice. They will cover a multitude of topics, such as a Focus on imaging - Calcified plaque assessment and PCI guidance by IVUS and OCT, Left main PCI guided with IVUS and OCT & Echo-guided arterial puncture.

A programme for Nurses and Allied Professionals comprising 9 sessions that share tips and tricks from experts, practical knowledge and up-to-date techniques for daily practice.

The dedicated EAPCI-PCR Fellows Course on the day before EuroPCR is designed for practitioners in the early stage of their professions. It is supported by the EAPCI Young and PCR NextGen, and has already announced a full house with a record number of participants.

PCR Innovators Day is being held on 15 May and will gather the field's key stakeholders: healthcare practitioners, academics, engineers and business professionals. It will be wrapped up with the Jon DeHaan Foundation’s generous award of a $200,000 grant for the best innovation.

NOTES TO EDITORS

About EuroPCR 2023

The World-Leading Course in interventional cardiovascular medicine and the official annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) will take place from 16 to 19 May 2023, onsite at the Palais des congrès, Paris, France. A digital package is also available for those unable to join in person.

The detailed Course Programme is available on: https://www.pcronline.com/Courses/EuroPCR  

The mission of PCR is to serve the needs of each individual patient by helping the cardiovascular community to share knowledge, experience and practice. PCR offers a large range of many other educational meetings and resources for the continuing education of the interventional cardiovascular community. These include major annual Courses across the globe, e-Learning with high-profile PCR Webinars, Courses specifically dedicated to valvular heart disease, tailor-made PCR Seminars on specific topics, online resources and medical publications such as EuroIntervention, the official journal of the EAPCI.

Gateways to all PCR activities are available on www.pcronline.com

For further information, please contact Sally Collingridge: [email protected]

About the EAPCI

The European Association of Percutaneous Cardiovascular Interventions (EAPCI) is a branch of the European Society of Cardiology. Its mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions. This dynamic association represents a community of over 8,700 healthcare professionals by helping them remain up to date in the constantly evolving field of PCI by publishing research and providing training and certification programmes. The EAPCI also advocates for the best possible access to life saving treatments for patients through data-based advocacy at a European level.

HELP FOR JOURNALISTS TO COVER EUROPCR 2023

Register and attend EuroPCR 2023 as a journalist

Open to accredited journalists, free of charge. Journalists must hold a valid press card and/or provide a letter of assignment from a recognised publication. To register as press, go to: https://www.pcronline.com/Courses/EuroPCR/Press

EuroPCR press releases can be found at: https://www.pcronline.com/News/PCR-Press-Releases

For any press-related enquiries, please contact EuroPCR Press Coordinator, Isabelle Uzielli: [email protected]

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Guided Tour

Welcome to EuroPCR ! Let us introduce the platform.

Happening Now

The live Course is happening here.

There are 9 channels broadcasting live content from the session rooms and Main Arena in the Palais des Congrès, Paris. In each of them you can ask questions and chat with your peers who are joining onsite or online.

New this year: the Studio EuroPCR+ channel is broadcasting live content and replays 24h/day, including the Daily News, so it is the perfect channel to watch outside of Course hours!

Consult the Programme and build your own by adding your sessions of interest to My Programme. You will be reminded when a session is about to begin.

New this year: the Replay tab provides access to all the sessions available on replay, in chronological order. Please note that replays are usually available about 24h after their original broadcast.

The VOD section includes a wide selection of videos, covering Abstracts, Case discussions, Innovations and Late-Breaking Trials, Expert Interviews, and Replays. If you missed anything, no need to worry, you will find it there shortly after its broadcast!

You can also save a video to Watch Later and view it at your convenience.

New this year: the Discover tab allows you to easily browse through a curated selection of videos not to be missed!

Scientific Abstract Book

Discover all of the EuroPCR 2022 submissions selected for presentation at the Course. Filter them by topic or use the free search.

You can rate, comment or contact each author.

Publications

The Publications page offers high-value resources such as the EuroPCR edition of EuroIntervention; free access to the PCR-EAPCI Textbook including 2 new chapters; the PCR Trials book; and a special offer for our PCR Companions!

Discover what our Industry Partners have in store for you! Each partner has curated a selection of content so you can learn about their products and easily get in touch.

Direct Messages

Open up Direct Messages and start a discussion with onsite and online participants, including those who are using the App.

EuroPCR is known to be a great networking event so make sure you take full advantage of this time to connect with your peers in Paris and all around the globe!

Access your profile, change your time zone if it is not correct (useful to display the right Programme times), access My Programme, Watch Later.

Anything that has to do with you and your preferences will be found here.

Do you have a question? Something is not working properly?

No problem, open the Help Desk at the bottom right corner of the screen and someone will assist you :)

17 - 20 May 2022

Access the course here using your my pcr account if you are not already logged in to my pcr you will be redirected to pcronline.com.

Connection will be available from 15 May

Check your device settings

Haven’t registered to EuroPCR yet?

Replay Discover all

Search terms

May 11, 2023

Philips showcases its latest portfolio of cardiology innovations that deliver clinical confidence and efficiency in treating cardiac disease at europcr 2023.

• Late-breaking data presented from largest-ever randomized controlled multicenter clinical trial on optimizing patient safety during coronary procedures
• Philips-hosted symposiums and onsite trainings to empower better heart care through integrated imaging, devices, software, informatics and services

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is showcasing end-to-end cardiology solutions through the care pathway at the annual meeting for the European Association of Percutaneous Cardiovascular Interventions (EuroPCR, May 16-19, Paris, France) to deliver better heart care for patients with greater efficiency. The Philips cardiology portfolio addresses the need for integrating imaging, devices, software, informatics, and services at each point in the cardiac patient journey. Philips’ proven physiology technologies can enable interventionalists to perform ultra-low contrast percutaneous coronary intervention (ULC-PCI) procedures with greater confidence.

Late-breaking clinical sessions on evidence-based coronary imaging

In line with the company’s commitment to supporting its innovations with clinical evidence, Philips’ clinical partners will present new data during late-breaking sessions at EuroPCR that could help inform treatment for PCI patients.  

• Dynamic coronary roadmap for contrast reduction trial (DCR4Contrast): Prof. Javier Escaned, Head of the Interventional Cardiology Section at Hospital Clinico San Carlos, Madrid Spain, will present results from the DCR4Contrast trial, the largest-ever randomized controlled clinical trial on this topic, which investigated the ability of Philips Dynamic Coronary Roadmap (DCR) to reduce the total iodinated contrast media volumes administered during percutaneous coronary intervention (PCI) procedures, compared to PCI performed without DCR guidance. The late-breaker presentation will take place on Tuesday, May 16 at 12:00 to 13:30 (CET) in Room Maillot. Prof. Escaned will also present the results from the DCR4Contrast trial and is available for questions during the EuroPCR 2023 Press Conference taking place on Tuesday 16 May from 08:05 – 09:15am CET in the Press Room on Level 3.
• iFR versus FFR-guided revascularization decision-making: Dr. Takayuki Warisawa, Interventional cardiologist at NTT Medical Center in Tokyo, Japan, will present new data on iFR versus FFR-guided revascularization decision-making in left main disease. The late-breaker presentation adds to a growing body of evidence showing iFR improves patient outcomes and optimizes procedural results. The session will take place on Tuesday 16 May from 12:00 to 13:00 CET in Room Maillot.
• DEFINE-FLAIR five-year follow-up: Prof. Javier Escaned will also present 5-year data from the DEFINE FLAIR clinical trial comparing patient outcomes using instant wave-free ratio (iFR) and fractional flow reserve (FFR) in the diagnosis and treatment of heart disease. The late-breaker presentation will take place on Thursday, May 18 from 15:15 to 16:45 CET in Room Maillot.
• Radiographic imaging validation and Evaluation for angio iFR (ReVEAL iFR): Dr. Yoshinobu Onuma will present the results of this multi-center, prospective, single-arm, open-label data collection with centralized off-line data analysis intended to demonstrate the diagnostic performance of angiographic-derived iFR single plane angiogram derived physiology model using the invasive physiological measures of both iFR and FFR as the reference standards. The late-breaker presentation will take place on Thursday, May 18 at 15:15 to 16:45 CET in Room Maillot.

More information on these sessions and the full EuroPCR 2023 program can be found here .

Highlight innovations from Philips’ cardiology portfolio on display at EuroPCR include Philips Image Guided Therapy System – Azurion , Philips Interventional Applications Platform – IntraSight , next to visualization solutions such as Philips Precision Guidance System – SyncVision , Philips Dynamic Coronary Roadmap , live echo and live X-ray fusion tool – EchoNavigator , Pressure Guide Wire – OmniWire and its intravascular ultrasound (IVUS) catheters . Next to this, Philips will showcase atherectomy solutions, such as RX PTCA Scoring Balloon Catheter – AngioSculpt Evo , and its coronary laser atherectomy catheter – ELCA . Live expert-led training sessions, symposiums and in-booth displays will give physicians and media insights into the latest developments in optimizing ULC-PCI procedures. Philips will also hold IVUS Simulation Sessions on recognizing different types of calcified plaque by intravascular ultrasound (IVUS) and optical coherence tomography. In the Philips Training Village visitors can learn more about how Philips solutions support interventionalists in minimizing the contrast load for the patient and physicians, and in performing interventional procedures with clarity and confidence using solutions such as IVUS, iFR, FFR and laser, improving cardiac care experiences for staff and patients. For a full calendar of Philips events, session registration and to learn more about cardiology solutions being showcased in Philips Booth #F20 at EuroPCR 2023, please visit our website .

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 74,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter .

By clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.

You are about to visit a Philips global content page

Media assets

AngioSculpt Evo balloon

Philips iFR

Philips IVUS

Philips Azurion

Philips Dynamic Coronary Roadmap

Philips OmniWire

Share on social media

• https://www.usa.philips.com/a-w/about/news/archive/standard/news/press/2023/20230511-philips-showcases-its-latest-portfolio-of-cardiology-innovations-that-deliver-clinical-confidence-and-efficiency-in-treating-cardiac-disease-at-europcr-2023.html Link copied

Related news

April 22, 2024

February 28, 2024

February 27, 2024

January 11, 2024

October 26, 2023

October 10, 2023

July 18, 2023

June 21, 2023

• Consumer products
• Product registration
• Healthcare professionals
• Specialties
• Other business solutions
• Hearing solutions
• Display solutions
• Dictation Solutions
• Investor Relations
• Environmental, Social and Governance
• Contact & support
• Customer support
• Professional healthcare support
• Company contacts
• Stay up-to-date Stay up-to-date

Select country

• Privacy Notice
• Terms of use
• Cookie notice
• Legal compliance

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

• Radcliffe Group
• Medical Education
• Content for healthcare professionals only

Content Type

EuroPCR Congress 2024 has revealed 2 late-breaking trial sessions, and 6 hot-line trial sessions to be presented in May. 

EuroPCR 2024 will be held from the 14th to 17th May at the Palais des Congrès de Paris in Paris, France. Access the full programme here.

Hotline: advances in coronary physiology

Tuesday 14th May, 11:45 – 13:15pm

• Influence of pathophysiological patterns of CAD on the safety and efficacy of PCI – Presented by Dr Carlos Collet
• Prognostic value of MRR in STEMI: a pooled analysis of individual patient data – Presented by Dr Mohamed El Farissi
• QFR for the revascularization of non-culprit lesions of older patients with myocardial infarction – Presented by Dr Andrea Erriquez
• Angiography-based radial wall strain in predicting non-culprit vessel failure – Presented by Dr Jiayue Huang
• Combining angiography and pre-specified intracoronary testing in patients with chronic coronary syndromes: the AID-ANGIO study – Presented by Dr Adrian Jeronimo
• FFRangio-based PCI were associated with better 1-year clinical outcomes in an international registry – Presented by Dr Yuetsu Kikuta
• Diagnostic performance of fully automatic computational FFR in the CAREER study – Presented by Dr Shengxian Tu
• Diagnostic accuracy of fully automatic Murray law-based quantitative flow ratio – Presented by Dr Daixin Ding

Late-breaking trials: TAVI head-to-head

• Self-expanding TAVI in patients with small aortic annuli: ancillary SMART trial analyses 2 – Presented by Dr Roxana Mehran
• Percutaneous versus surgical treatment for patients with aortic stenosis and coronary disease – Presented by Dr Elvin Kedhi
• Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial – Presented by Dr Hans-josef Feistritzer
• Long-term multiple comparison of transcatheter aortic valves – insights from the OBSERVANT II study – Presented by Dr Giuliano Costa
• Comparison of self-expanding versus balloon-expandable transcatheter aortic valves: 1-year outcomes – Presented by Dr Wom-Keun Kim
• Balloon-expandable versus self-expanding transcatheter valves in raphe-type bicuspid aortic stenosis – Presented by Dr Andrea Buono

Hotline: new coronary devices (DES, BRS, DCB)

Tuesday 14th May, 15:15 – 16:45pm

• A randomised trial of iron bioresorbable scaffold compared with XIENCE in coronary artery disease – Presented by Dr Lei Song
• Site-specific antithrombotic therapy: DESyne BDS Plus study 12-month outcomes – Presented by Dr Alexandre Abizaid
• Two-year clinical outcomes of the BIOADAPTOR RCT study – Presented by Dr Shigeru Saito
• Results of the magnesium BRS in complex lesions: data from the IT-Masters registry – Presented by Dr Stefano Galli
• Randomised trial of biolimus vs paclitaxel coated balloons for coronary in-stent restenosis – Presented by Dr Lei Gao
• Sirolimus vs paclitaxel DCB. A logistic regression analysis of EASTBOURNE and PEARL multicentre study – Presented by Dr Bernardo Cortese
• Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study – Presented by Dr Roxana Mehran
• Patient and procedure characteristics for 1000 Selution SLRTM sirolimus-eluting balloon procedures – Presented by Dr Simon Eccleshall

Major Late-Breaking Trials from EuroPCR 2024

Wednesday 15th May, 08:30 – 10:00am

• One-month DAPT followed by 5-month Ticagrelor monotherapy in acute coronary syndromes with DCB – Presented by Dr Tao Ling
• First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2 – Presented by Prof Ole De Backer
• Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial – Presented by Dr Patrick Serruys

Randomised trials: substudies and extended follow-up - A quick update

• Keep bIfurcation Single stenting Simple – Presented by Dr Bernard Chevalier
• ORBITA2-Symptoms: the symptom-stratified analysis of ORBITA-2 – Presented by Dr Florentina Simander
• Does completeness of revascularisation affect clinical outcomes? Insights from REVIVED-BCIS2 – Presented by Dr Margaret Mcentegart
• Is coronary artery bypass surgery cost-effective compared with contemporary PCI – Presented by Dr Frederik Zimmermann
• Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study – Presented by Dr Mateusz Tajstra
• Long-term outcomes after immediate versus staged complete revascularisation in STEMI or NSTE-ACS – Presented by Dr Roberto Diletti
• Improved DES for left main PCI in an all-comers population: 5-year results of the IDEAL-LM Trial – Presented by Dr Robert Van Geuns

TAVI hotline: long-term registry data

Wednesday 15th May, 10:30am – 12:00pm

• Surgical versus transcatheter approach in combined coronary and aortic valve disease – Presented by Dr Ignacio J Amat-Santos
• Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement – Presented by Dr Eliano Navarese
• A prospective multicentre registry of a short-frame supra-annular transcatheter aortic valve – Presented by Dr Holger Thiele
• Initial experience of a novel intra-annular self-expanding transcatheter aortic valve in Japan – Presented by Dr Kentaro Hayashida
• Redefining small aortic annulus in patients receiving a self-expanding transcatheter aortic valve – Presented by Dr Michael Reardon
• TAVR with a self-expandable bioprothesis: 12-year clinical and durability data – Presented by Dr Luca Testa
• Long term clinical outcomes of the MyVal valve in patients with severe aortic stenosis – Presented by Dr Teoman Kilic

TAVI Hotline: new devices, new approaches

Wednesday 15th May, 14:45 – 16:15pm

• First report of an IDE pivotal study of a dedicated splitting device during TAVR – Presented by Dr Danny Dvir
• Upper extremity versus lower extremity for accessory access sites during TAVI – Presented by Dr Geert Versteeg
• DurAVR biomimetic transcatheter heart valve: early feasibility study update – Presented by Dr Christopher Meduri
• One-year efficacy and safety of the dry-pericardium aortic valve: A first-in-human feasibility study – Presented by Dr Kasparas Briedis
• Using temporary permanent pacemaker as a one-month bridge after TAVI – Presented by Dr Guanyuan Song
• Clinical evaluation of the Hydra self-expanding THV: 30 days results from the GENESIS-II study – Presented by Dr Nagendra Boopathy Senguttuvan

First-in-man and out-of-the-box innovations hotline

• BackBeat: Atrio-Ventricular Interval Modulation (AVIM) for blood pressure control – Presented by Dr Avi Fischer
• First-in-Man safety and efficacy of renal stimulation with direct wire pacing during denervation procedure – Presented by Dr Benjamin Faurie
• Results of the REDUCED 1 study assessing the TIVUS system in renal denervation – Presented by Dr James Zidar
• Radial approach renal denervation: first-in-man study with the 4F TIVUS system – Presented by Dr Michael Jonas
• Renal Denervation as a day case procedure – Presented by Dr Eileen Coen
• Multicenter registry on robotically assisted percutaneous coronary interventions - TESLA registry – Presented by Dr Dariusz Dudek
• Robotic Tele-Surgery Stenting – Presented by Dr Pradip Kumar Karmakar
• Advances in Holographic Imaging for Procedural Planning and Guidance (Realview Imaging) – Presented by Dr Elchanan Bruckheimer

First results of randomised trials on advanced plaque modification techniques and intracoronary imaging

Thursday 16th May, 10:30am – 12:00pm

• Does OCT optimise results of stenting on the left main: a randomised, controlled, multicentre trial – Presented by Dr Nicolas Meneveau
• Primary outcome of randomised controlled trial of the safety and effectiveness for OCT or IVUS-guide – Presented by Dr Shanshan Zhou
• OCT vs. angiography for guidance of calcified lesions PCI: the CALIPSO trial – Presented by Dr Nicolas Amabile
• Debulking with rotational atherectomy versus balloon angioplasty in patients with in-stent restenosis – Presented by Dr Do-Yoon Kang
• The laser atherectomy for STEMI, PCI analysis with scintigraphy study – Presented by Dr Kensuke Takagi
• Balloon angioplasty versus shockwave intravascular lithotripsy – Presented by Dr Bernard Wong
• Rotational atherectomy, lithotripsy or laser for calcified coronary stenosis – Presented by Dr Alfonso Jurado

Mitral and tricuspid hotline

Thursday 16th May, 14:45 – 16:15pm

• Transcatheter mitral repair in patients with moderate mitral regurgitation: one-year outcomes from the MiCLASP study – Presented by Dr Philipp Lurz
• Impact of intra-procedural residual mitral regurgitation and gradient following TEER for primary mitral regurgitation – Presented by Dr Augustin Coisne
• Report on the AltaValve early feasibility study – Presented by Dr Vlasis Ninios
• One-year outcomes of transcatheter edge-to-edge repair for primary tricuspid regurgitation – Presented by Dr Atsushi Sugiura
• Impact of residual tricuspid regurgitation after transcatheter tricuspid valve repair on survival – Presented by Dr Julien Dreyfus
• Transcatheter tricuspid valve implantation using the LuxValvePlus system: compassionate use outcomes – Presented by Dr Jorg Hausleiter
• Multivalvular disease in TAVR-patients: Multicentre study on impact of staged valvular interventions – Presented by Dr Baravan Al-Kassou

Treating today, ready for tomorrow

Key outcomes from tvt 2021.

Watch a replay of the Early neo2 Core-Lab Results presentation >

Medical Specialties > Structural Heart  >  TVT 2021 Clinical Presentation

Early neo2 Registry Core-Lab Analysis 1

12 sites  |  n = 554 patients, the early neo2 registry is an investigator-initiated and conducted, single arm, multicenter registry that assessed the acurate neo2 aortic valve system’s performance. 1.

Early neo2 Registry Core-Lab Results (TVT, 2021)

Clinical outcomes.

The ACURATE neo2 Valve performed consistently for key patient outcomes:

moderate/severe PVL*

mean gradient*

new permanent pacemaker †

stroke rate †

mortality ‡

coronary obstruction §

Paravalvular Leak Comparison

The independent Early neo2 Registry’s core-lab analysis studied 85% of the original study’s 554 patients.

Post-Procedure PVL

Percent of evaluable echocardiograms demonstrating post-procedure PVL rates from the core-lab adjudicated Early neo2 Registry. 2

Authentication

Please type your Last Name and First Name to download your certificate of presentation

Advertisement

• PCRonline /
• Cases & Resources /

PCR Course webcasts, videos & slides in interventional cardiology

The living memory of PCR Courses is captured in this section, a dynamic look at the recorded events at the heart of our clinical knowledge and learning experience in interventional cardiovascular medecine. Whether you’re looking for a LIVE demonstration, a specific session, clinical case or slide presentation , you’ll find the elements that make PCR a valuable and continuous online learning experience. These resources are all freely available (a My PCR account is required to access certain types of content).

• Acute heart failure
• Below the knee
• Bifurcation lesion
• Carotid stenting
• Chronic heart failure
• Iliac / Femoral / Popliteal
• Intracoronary imaging
• Ischaemic stroke
• LAA closure
• Left main and multivessel disease
• Left main disease
• Mitral valve replacement and repair
• Multivessel disease
• Other coronary interventions
• Other hypertension
• Other peripheral interventions
• Other stroke interventions
• Other valvular and structural interventions
• Pharmacology
• Renal artery angioplasty
• Renal denervation
• Stents, scaffolds and DCB
• Structural imaging
• Tricuspid / Pulmonary valve
• Course highlight
• Editorial webcast
• Hot line / Late-Breaking Trials
• Scientific session video
• Session with LIVE case
• Session wrap-up
• Sponsored session video
• AICT-AsiaPCR
• GulfPCR-GIM
• PCR Imaging Valves Madrid
• PCR Innovators Day
• PCR London Valves
• PCR Tokyo Valves
• PCR Valves e-Course
• PCR e-Course

2707 results

Navigating TAVI Complications: Strategies for Success

17 May 2024 – From EuroPCR 2024

Mastering the Recovery of Lost Stents in PCI

LIVE Case: Imaging-Guided Left Main PCI

Optimizing PCI for Angina and Coronary Disease Management

PCI of bifurcation lesions: management of complications - Part 3

New evidence on TAVI from PCR Companions

Imaging and physiology guided PCI

Mastering PCI Complications - Part 2

EuroPCR 2024 Closing Ceremony

Navigating Complex ACS Scenarios: Strategies for Success

Conquering High Clot Burden in STEMI: Strategies and Tools

Safeguarding TAVI: Strategies to Prevent Stroke

• ← previous
• next →